RFWD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.526400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.864000E-01
Normal-vs-Stage2
7.312600E-01
Normal-vs-Stage3
1.625400E-01
Normal-vs-Stage4
7.673200E-01
Stage1-vs-Stage2
4.684600E-01
Stage1-vs-Stage3
3.350100E-02
Stage1-vs-Stage4
1.741790E-01
Stage2-vs-Stage3
2.13259999999327E-05
Stage2-vs-Stage4
3.863000E-01
Stage3-vs-Stage4
5.027900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.588000E-01
Normal-vs-AfricanAmerican
9.238600E-01
Normal-vs-Asian
4.477000E-01
Caucasian-vs-AfricanAmerican
6.553200E-01
Caucasian-vs-Asian
3.096600E-01
AfricanAmerican-vs-Asian
3.787200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.026000E-01
Normal-vs-Female
7.262400E-01
Male-vs-Female
5.484600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.990000E-01
Normal-vs-Age(41-60Yrs)
9.653200E-01
Normal-vs-Age(61-80Yrs)
5.396200E-01
Normal-vs-Age(81-100Yrs)
6.961200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.251800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.976200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.738400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.699900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.589400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.662200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.381400E-01
Normal-vs-Daily Drinker
2.672600E-01
Normal-vs-Weekly Drinker
7.958400E-01
Normal-vs-Occasional Drinker
9.378600E-01
Normal-vs-Social Drinker
9.352200E-01
Non Drinker-vs-Daily Drinker
3.366000E-01
Non Drinker-vs-Weekly Drinker
6.063000E-01
Non Drinker-vs-Occasional Drinker
2.306800E-01
Non Drinker-vs-Social Drinker
1.735440E-01
Daily Drinker-vs-Weekly Drinker
2.158200E-01
Daily Drinker-vs-Occasional Drinker
3.337500E-02
Daily Drinker-vs-Social Drinker
2.860100E-02
Weekly Drinker-vs-Occasional Drinker
6.590800E-01
Weekly Drinker-vs-Social Drinker
5.373200E-01
Occasional Drinker-vs-Social Drinker
7.677000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.775800E-01
Normal-vs-Grade 2
9.506000E-01
Normal-vs-Grade 3
8.711600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.282360E-01
Grade 1-vs-Grade 3
8.339900E-03
Grade 1-vs-Grade 4
9.775800E-01
Grade 2-vs-Grade 3
4.652000E-02
Grade 2-vs-Grade 4
9.506000E-01
Grade 3-vs-Grade 4
8.711600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.372400E-01
Normal-vs-NonDiabetic
5.948000E-01
Diabetic-vs-NonDiabetic
6.784000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.245800E-01
Normal-vs-NoPancreatitis
6.202200E-01
Pancreatitis-vs-NoPancreatitis
6.959400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.956200E-01
Normal-vs-N1
7.175400E-01
N0-vs-N1
7.504800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.312000E-01
Normal-vs-TP53-NonMutant
7.427600E-01
TP53-Mutant-vs-TP53-NonMutant
6.376000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
